HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
نویسندگان
چکیده
منابع مشابه
Homocysteine-lowering therapy improved outcomes after percutaneous coronary intervention.
M a i n r e s u l t s Analysis was by intention to treat. The composite endpoint of any major coronary adverse outcome was lower in the homocysteine-lowering group than the placebo group, as was the need for repeated revascularization and repeated target lesion revascularization (Table). Adjustment for age, sex, and risk factors known to influence the need for repeated revascularization did not...
متن کاملRisk stratification for long-term mortality after percutaneous coronary intervention.
BACKGROUND A simple risk score to predict long-term mortality after percutaneous coronary intervention (PCI) using preprocedural risk factors is currently not available. In this study, we created one by simplifying the results of a Cox proportional hazards model. METHODS AND RESULTS A total of 11,897 patients who underwent PCI from October through December 2003 in New York State were randomly...
متن کاملAntiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Thrombosis plays a major role in acute vessel closure both after coronary balloon angioplasty and after stenting. This review will address the role of antiplatelet and anticoagulant therapy in preventing early thrombotic complications after percutaneous coronary intervention. The focus will be on agents that are routinely available and commonly used.
متن کاملSame day discharge after elective percutaneous coronary intervention.
Same-day percutaneous coronary intervention (PCI) is a reality with modern interventional equipment and pharmaceutical agents. Elective PCI is rarely an inpatient procedure and is now predominantly considered an outpatient procedure. Approaches to safely manage elective patients through same-day PCI have been well described in the literature and demonstrate no safety signal compared with overni...
متن کاملShort- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.
Platelets play a central role in both the short- and long-term manifestations of atherothrombosis. In acute coronary syndrome (ACS), there is a steep rise in cardiovascular events early, followed by an incremental rise in cardiovascular events over the long term. This long-term event rate is related to persistent platelet activation and thrombin generation. There is therefore a need to optimize...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rational Pharmacotherapy in Cardiology
سال: 2011
ISSN: 2225-3653,1819-6446
DOI: 10.20996/1819-6446-2011-7-5-524-535